Rare Disease Drug Market Report

Global and Region Rare Disease Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：195
  • REPORT CODE：GMM1021754
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rare disease drugs refer to the drugs that are used for rare diseases or have little commercial value, and no pharmaceutical company is willing to invest in the development of drugs. The definition of rare diseases is defined as 5/10000 of patients with less than 200 thousand patients or less than the incidence rate. There are 5000-6000 kinds of rare diseases, accounting for about 10% of human diseases.

    With the COVID-19 outbreak in 2019, the global economy has been hit hard to some extent, but the health sector has been less affected. According to the forecast, the Rare Disease Drug market will maintain steady market growth over the forecast period and eventually achieve a compound annual growth rate of 11.5%.

    The government has been instrumental in the development of the market for Rare Disease Drug. First, the government collects a smaller tax on companies that produce or research Rare Disease Drug. Second, the government has legally given more licenses to the production of Rare Disease Drug. These are all positive drivers of the global market for Rare Disease Drug.

    The report details the trend, potential and market size of Rare Disease Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Rare Disease Drugmarket, defines the market attractiveness level of Rare Disease Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Rare Disease Drug industry, describes the types of Rare Disease Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rare Disease Drug market and the development prospects and opportunities of Rare Disease Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rare Disease Drug market in Chapter 13.

    By Player:

    • Biogen, Inc

    • AstraZeneca

    • Shire

    • Bristol-Myers Squibb Company

    • Sanofi SA

    • Daiichi Sankyo Company Limited

    • ProQR

    • GlaxoSmithKline

    • Eli Lilly and Company

    • Novartis AG

    • Alexion Pharmaceuticals, Inc

    • Pfizer, Inc

    • Amgen, Inc

    • Johnson & Johnson

    • Novo Nordisk A/S

    • F Hoffmann-La Roche Ltd

    • Eisai Co, Ltd

    • Merck & Co, Inc

    • Celgene Corporation

    • Deciphera

    • Atara Biotherapeutics

    • Bayer AG

    By Type:

    • >1%

    • 065%~1%

    • <01%

    By End-User:

    • Hospital Pharmacies

    • Speciality Pharmacies

    • Retail pharmacies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Rare Disease Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Rare Disease Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Rare Disease Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Rare Disease Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Rare Disease Drug Market Analysis and Outlook to 2022

    • 7.1 Global Rare Disease Drug Consumption (2017-2022)

    • 7.2 United States Rare Disease Drug Consumption (2017-2022)

    • 7.3 Europe Rare Disease Drug Consumption (2017-2022)

    • 7.4 China Rare Disease Drug Consumption (2017-2022)

    • 7.5 Japan Rare Disease Drug Consumption (2017-2022)

    • 7.6 India Rare Disease Drug Consumption (2017-2022)

    • 7.7 South Korea Rare Disease Drug Consumption (2017-2022)

    8 Region and Country-wise Rare Disease Drug Market Analysis and Outlook to 2028

    • 8.1 Global Rare Disease Drug Consumption Forecast (2022-2028)

    • 8.2 United States Rare Disease Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Rare Disease Drug Consumption Forecast (2022-2028)

    • 8.4 China Rare Disease Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Rare Disease Drug Consumption Forecast (2022-2028)

    • 8.6 India Rare Disease Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Rare Disease Drug Consumption Forecast (2022-2028)

    9 Global Rare Disease Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Rare Disease Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global >1% Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 065%~1% Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global <01% Consumption and Growth Rate (2017-2022)

    • 9.2 Global Rare Disease Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Rare Disease Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Rare Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global >1% Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 065%~1% Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global <01% Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Rare Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Rare Disease Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Rare Disease Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Rare Disease Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Rare Disease Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Rare Disease Drug Market Competitive Analysis

    • 14.1 Biogen, Inc

      • 14.1.1 Biogen, Inc Company Details

      • 14.1.2 Biogen, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biogen, Inc Rare Disease Drug Product and Service

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Details

      • 14.2.2 AstraZeneca Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca Rare Disease Drug Product and Service

    • 14.3 Shire

      • 14.3.1 Shire Company Details

      • 14.3.2 Shire Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Shire Rare Disease Drug Product and Service

    • 14.4 Bristol-Myers Squibb Company

      • 14.4.1 Bristol-Myers Squibb Company Company Details

      • 14.4.2 Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bristol-Myers Squibb Company Rare Disease Drug Product and Service

    • 14.5 Sanofi SA

      • 14.5.1 Sanofi SA Company Details

      • 14.5.2 Sanofi SA Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi SA Rare Disease Drug Product and Service

    • 14.6 Daiichi Sankyo Company Limited

      • 14.6.1 Daiichi Sankyo Company Limited Company Details

      • 14.6.2 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Daiichi Sankyo Company Limited Rare Disease Drug Product and Service

    • 14.7 ProQR

      • 14.7.1 ProQR Company Details

      • 14.7.2 ProQR Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 ProQR Rare Disease Drug Product and Service

    • 14.8 GlaxoSmithKline

      • 14.8.1 GlaxoSmithKline Company Details

      • 14.8.2 GlaxoSmithKline Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 GlaxoSmithKline Rare Disease Drug Product and Service

    • 14.9 Eli Lilly and Company

      • 14.9.1 Eli Lilly and Company Company Details

      • 14.9.2 Eli Lilly and Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Eli Lilly and Company Rare Disease Drug Product and Service

    • 14.10 Novartis AG

      • 14.10.1 Novartis AG Company Details

      • 14.10.2 Novartis AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis AG Rare Disease Drug Product and Service

    • 14.11 Alexion Pharmaceuticals, Inc

      • 14.11.1 Alexion Pharmaceuticals, Inc Company Details

      • 14.11.2 Alexion Pharmaceuticals, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Alexion Pharmaceuticals, Inc Rare Disease Drug Product and Service

    • 14.12 Pfizer, Inc

      • 14.12.1 Pfizer, Inc Company Details

      • 14.12.2 Pfizer, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Pfizer, Inc Rare Disease Drug Product and Service

    • 14.13 Amgen, Inc

      • 14.13.1 Amgen, Inc Company Details

      • 14.13.2 Amgen, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Amgen, Inc Rare Disease Drug Product and Service

    • 14.14 Johnson & Johnson

      • 14.14.1 Johnson & Johnson Company Details

      • 14.14.2 Johnson & Johnson Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Johnson & Johnson Rare Disease Drug Product and Service

    • 14.15 Novo Nordisk A/S

      • 14.15.1 Novo Nordisk A/S Company Details

      • 14.15.2 Novo Nordisk A/S Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novo Nordisk A/S Rare Disease Drug Product and Service

    • 14.16 F Hoffmann-La Roche Ltd

      • 14.16.1 F Hoffmann-La Roche Ltd Company Details

      • 14.16.2 F Hoffmann-La Roche Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 F Hoffmann-La Roche Ltd Rare Disease Drug Product and Service

    • 14.17 Eisai Co, Ltd

      • 14.17.1 Eisai Co, Ltd Company Details

      • 14.17.2 Eisai Co, Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Eisai Co, Ltd Rare Disease Drug Product and Service

    • 14.18 Merck & Co, Inc

      • 14.18.1 Merck & Co, Inc Company Details

      • 14.18.2 Merck & Co, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Merck & Co, Inc Rare Disease Drug Product and Service

    • 14.19 Celgene Corporation

      • 14.19.1 Celgene Corporation Company Details

      • 14.19.2 Celgene Corporation Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Celgene Corporation Rare Disease Drug Product and Service

    • 14.20 Deciphera

      • 14.20.1 Deciphera Company Details

      • 14.20.2 Deciphera Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Deciphera Rare Disease Drug Product and Service

    • 14.21 Atara Biotherapeutics

      • 14.21.1 Atara Biotherapeutics Company Details

      • 14.21.2 Atara Biotherapeutics Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Atara Biotherapeutics Rare Disease Drug Product and Service

    • 14.22 Bayer AG

      • 14.22.1 Bayer AG Company Details

      • 14.22.2 Bayer AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Bayer AG Rare Disease Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Rare Disease Drug

    • Figure Rare Disease Drug Picture

    • Table Global Rare Disease Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rare Disease Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rare Disease Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Rare Disease Drug Consumption by Country (2017-2022)

    • Figure United States Rare Disease Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Rare Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure China Rare Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Rare Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure India Rare Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Rare Disease Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Rare Disease Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Rare Disease Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global >1% Consumption and Growth Rate (2017-2022)

    • Figure Global 065%~1% Consumption and Growth Rate (2017-2022)

    • Figure Global <01% Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Speciality Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global >1% Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 065%~1% Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global <01% Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Speciality Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Rare Disease Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Rare Disease Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Biogen, Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen, Inc Rare Disease Drug Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Rare Disease Drug Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Rare Disease Drug Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Rare Disease Drug Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Rare Disease Drug Product and Service

    • Table Daiichi Sankyo Company Limited (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company Limited Rare Disease Drug Product and Service

    • Table ProQR (Foundation Year, Company Profile and etc.)

    • Table ProQR Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProQR Rare Disease Drug Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Rare Disease Drug Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Rare Disease Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Rare Disease Drug Product and Service

    • Table Alexion Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Alexion Pharmaceuticals, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Pharmaceuticals, Inc Rare Disease Drug Product and Service

    • Table Pfizer, Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc Rare Disease Drug Product and Service

    • Table Amgen, Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen, Inc Rare Disease Drug Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Rare Disease Drug Product and Service

    • Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk A/S Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S Rare Disease Drug Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Rare Disease Drug Product and Service

    • Table Eisai Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Eisai Co, Ltd Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Co, Ltd Rare Disease Drug Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Rare Disease Drug Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Rare Disease Drug Product and Service

    • Table Deciphera (Foundation Year, Company Profile and etc.)

    • Table Deciphera Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Deciphera Rare Disease Drug Product and Service

    • Table Atara Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Atara Biotherapeutics Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atara Biotherapeutics Rare Disease Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Rare Disease Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Rare Disease Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US